Five HIV patients left ‘virus-free’ with no need for daily drugs in early vaccine trials
Monday, February 27, 2017
Researchers combined two innovative HIV vaccines with a drug usually used to treat cancer in the trial, conducted over three years at the IrsiCaixa Aids Research Institute in Barcelona.
After receiving the treatment, the virus was undetectable in five out of 24 participants and its spread was stopped by their immune systems, reported the New Scientist. One of them has been drug-free for seven months.
Lead scientist Beatriz Mothe said her team was “on the right path” to developing a treatment which could offer an alternative to daily antiretroviral medication (ART).
Around 18 million people – half of all those living with HIV around the world – take ART to slow the progression of the infection, according to the UN. But these drugs are expensive and can cause unpleasant side effects. Patients have to remember to take them every day, sometimes over their entire lives.
- Health Care